Consumption of Eggs Rich in Lutein and Omega-3 Fatty Acids on the Macular Pigment (ALGOVUE)

August 2, 2013 updated by: Jean-Michel Lecerf, Institut Pasteur de Lille

Effect of Consumption of Eggs Rich in Xanthophyll Carotenoids and Omega-3 Fatty Acids on the Macular Pigment in Healthy People

This study is to determine the impact of the consumption of eggs rich in lutein/zeaxanthin from lucerne protein concentrate and DHA from microalgae on the plasma levels of these compounds but also on the macular pigment optical density, whose elevation may be beneficial in the prevention of Age-related Macular Degeneration (AMD).

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

99

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lille, France, 59000
        • Institut Pasteur de Lille

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • healthy subjects (male or female),
  • 18 to 55 years
  • Having signed the consent form,
  • Susceptible to accept the stresses generated by the study,
  • Insured.

Exclusion Criteria:

  • Corrected Visual Acuity <8/10th,
  • History of cardiovascular disease, specifically coronary heart disease,
  • Characterized dyslipidemia

    * Total cholesterol ³ 2.50 g / L, and / or triglycerides ³ 2.00 g / L

  • Lipid-lowering treatment,
  • Current smoking or person who stopped smoking less than 6 months
  • Cataract or cataract surgery,
  • Diabetes
  • Body Mass Index (BMI)> 30 kg/m2,
  • Taking food supplements in the 3 months preceding the start of the study (carotenoids, omega-3 fatty acids, phytosterols),
  • Regular consumption in the three months preceding the start of the study products with added phytosterols.
  • Regular consumption of high fatty fish or shellfish rich in omega-3 (4x a week or more): salmon, sardines, mackerel, herring, trout, tuna, red mullet, sea bass, bream, farmed turbot, mussels, squid / squid, anchovies.
  • Allergy to eggs
  • Dieting
  • Difference significant weight over the last 3 months (> 3 kg)
  • Inability to understand or adhere to the protocol
  • Persons deprived of liberty
  • People in a position to judicial protection
  • Pregnant Women.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: rich-eggs
subjects consume 2 eggs rich in lutein/zeaxanthin and DHA per day during 4 months
subjects consume 2 eggs per day during 4 months
Active Comparator: standard eggs
subjects consume 2 standard eggs per day
subjects consume 2 eggs per day during 4 months

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change from baseline in optical density of macular pigment after 4 months of eggs consumption
Time Frame: before the eggs consumption and four months afterwards
optical density of macular pigment was measured with a Heidelberg Retinal Angiograph (HRA)specially modify for the measure of the pigment.
before the eggs consumption and four months afterwards

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change from baseline in lutein and zeaxanthin in plasma and lipoproteins after 4 months of egg consumption
Time Frame: before the eggs consumption and four months afterwards
lutein and zeaxanthin were measured by HPLC
before the eggs consumption and four months afterwards
change from baseline in fatty acids in plasma and lipoproteins after 4 months of egg consumption
Time Frame: before the eggs consumption and four months afterwards
Fatty acids were measured by Gas Chromatography.
before the eggs consumption and four months afterwards

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Jean-Michel LECERF, MD, Institut Pasteur de Lille

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2011

Primary Completion (Actual)

February 1, 2013

Study Completion (Actual)

February 1, 2013

Study Registration Dates

First Submitted

September 13, 2011

First Submitted That Met QC Criteria

November 28, 2011

First Posted (Estimate)

November 29, 2011

Study Record Updates

Last Update Posted (Estimate)

August 5, 2013

Last Update Submitted That Met QC Criteria

August 2, 2013

Last Verified

August 1, 2013

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Age-related Macular Degeneration

Clinical Trials on Nutritional study

3
Subscribe